Helen I. Torley
2018
Compensation breakdown
| Non-Equity Incentive Plan | $831,665 |
|---|---|
| Option Awards | $2,115,631 |
| Salary | $725,000 |
| Stock Awards | $2,115,640 |
| Other | $11,733 |
| Total | $5,799,669 |
Torley received $2.1M in stock awards, accounting for 36% of the total pay in 2018.
Torley also received $831.7K in non-equity incentive plan, $2.1M in option awards, $725K in salary and $11.7K in other compensation.
Rankings
In 2018, Helen I. Torley's compensation ranked 1,640th out of 14,244 executives tracked by ExecPay. In other words, Torley earned more than 88.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,640 out of 14,244 | 89th |
Division Manufacturing | 583 out of 5,759 | 90th |
Major group Chemicals And Allied Products | 182 out of 2,122 | 91st |
Industry group Drugs | 145 out of 1,811 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 35 out of 339 | 90th |
Pay ratio
| Helen I. Torley's Pay | $5,799,669 |
|---|---|
| Median Employee's Pay | $199,899 |
| Pay Ratio | 29to 1 |
In 2018, the annual total compensation of Helen I. Torley was $5,799,669.
The annual total compensation of the median employee at Halozyme Therapeutics was $199,899.
The ratio of Helen I. Torley's pay to the pay of median employee was therefore 29 to one.
Torley's colleagues
We found four more compensation records of executives who worked with Helen I. Torley at Halozyme Therapeutics in 2018.
News
March 25, 2022
March 26, 2021
March 20, 2020
March 22, 2019